The Dosing Strategy to Improve Adherence to Roflumilast in Treatment for Chronic Obstructive Lung Disease: A Systemic Review and Meta-Analysis
Jonghoo Lee,1,* Jae-Uk Song2,* 1Department of Internal Medicine, Jeju National University Hospital, Jeju National University School of Medicine, Jeju, Republic of Korea; 2Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Kangbuk Samsung Hospital, Sung...
Main Authors: | Lee J, Song JU |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2024-03-01
|
Series: | International Journal of COPD |
Subjects: | |
Online Access: | https://www.dovepress.com/the-dosing-strategy-to-improve-adherence-to-roflumilast-in-treatment-f-peer-reviewed-fulltext-article-COPD |
Similar Items
-
Roflumilast – a phosphodiesterase-4 inhibitor licensed for add-on therapy in severe COPD
by: Anne B Taegtmeyer, et al.
Published: (2012-07-01) -
Roflumilast as a Potential Therapeutic Agent for Cecal Ligation and Puncture-Induced Septic Lung Injury
by: Zafer Bayraktutan, et al.
Published: (2022-02-01) -
Effect of Roflumilast in airways disorders via dual inhibition of phosphodiesterase and Ca2+-channel
by: Faisal Imam, et al.
Published: (2020-06-01) -
Roflumilast Powders for Chronic Obstructive Pulmonary Disease: Formulation Design and the Influence of Device, Inhalation Flow Rate, and Storage Relative Humidity on Aerosolization
by: Mohammad A. M. Momin, et al.
Published: (2021-08-01) -
Roflumilast tópico y oral en dermatología. Una revisión narrativa
by: M. Mansilla-Polo, et al.
Published: (2024-03-01)